A detailed history of Jpmorgan Chase & CO transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 22,077 shares of INZY stock, worth $97,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,077
Previous 61,577 64.15%
Holding current value
$97,580
Previous $471,000 79.19%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.33 - $7.31 $171,035 - $288,745
-39,500 Reduced 64.15%
22,077 $98,000
Q1 2024

May 10, 2024

BUY
$4.14 - $7.66 $112,777 - $208,666
27,241 Added 79.34%
61,577 $471,000
Q4 2023

Feb 12, 2024

BUY
$2.71 - $4.5 $33,430 - $55,512
12,336 Added 56.07%
34,336 $146,000
Q3 2023

Nov 14, 2023

SELL
$4.09 - $7.0 $17,607 - $30,135
-4,305 Reduced 16.37%
22,000 $92,000
Q2 2023

Aug 11, 2023

BUY
$4.93 - $6.74 $129,387 - $176,891
26,245 Added 43741.67%
26,305 $146,000
Q2 2022

Aug 11, 2022

SELL
$3.2 - $5.96 $994,793 - $1.85 Million
-310,873 Reduced 99.98%
60 $0
Q1 2022

May 11, 2022

SELL
$3.87 - $7.55 $52,066 - $101,577
-13,454 Reduced 4.15%
310,933 $1.27 Million
Q4 2021

Feb 10, 2022

SELL
$5.58 - $11.5 $41,872 - $86,296
-7,504 Reduced 2.26%
324,387 $2.21 Million
Q3 2021

Nov 12, 2021

BUY
$11.12 - $19.4 $3.69 Million - $6.44 Million
331,891 New
331,891 $3.85 Million

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $177M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.